154 related articles for article (PubMed ID: 8704963)
21.
Sharma S; Bhatnagar R; Gaur D
Front Immunol; 2020; 11():462. PubMed ID: 32296419
[No Abstract] [Full Text] [Related]
22. Role of suilysin in pathogenesis of Streptococcus suis capsular serotype 2.
Lun S; Perez-Casal J; Connor W; Willson PJ
Microb Pathog; 2003 Jan; 34(1):27-37. PubMed ID: 12620382
[TBL] [Abstract][Full Text] [Related]
23. Streptococcus suis serotype 2 strains can induce the formation of neutrophil extracellular traps and evade trapping.
Zhao J; Pan S; Lin L; Fu L; Yang C; Xu Z; Wei Y; Jin M; Zhang A
FEMS Microbiol Lett; 2015 Mar; 362(6):. PubMed ID: 25673283
[TBL] [Abstract][Full Text] [Related]
24. In vitro studies on the interaction between mouse peritoneal macrophages and strains of Salmonella and Escherichia coli.
JENKIN C; BENACERRAF B
J Exp Med; 1960 Aug; 112(2):403-17. PubMed ID: 13789820
[TBL] [Abstract][Full Text] [Related]
25. Role of the capsular polysaccharide as a virulence factor for Streptococcus suis serotype 14.
Roy D; Auger JP; Segura M; Fittipaldi N; Takamatsu D; Okura M; Gottschalk M
Can J Vet Res; 2015 Apr; 79(2):141-6. PubMed ID: 25852230
[TBL] [Abstract][Full Text] [Related]
26. Identification and characterization of the cps locus of Streptococcus suis serotype 2: the capsule protects against phagocytosis and is an important virulence factor.
Smith HE; Damman M; van der Velde J; Wagenaar F; Wisselink HJ; Stockhofe-Zurwieden N; Smits MA
Infect Immun; 1999 Apr; 67(4):1750-6. PubMed ID: 10085014
[TBL] [Abstract][Full Text] [Related]
27. Involvement of NF-kappaB and MAP-kinases in the transcriptional response of alveolar macrophages to Streptococcus suis.
de Greeff A; Benga L; Wichgers Schreur PJ; Valentin-Weigand P; Rebel JM; Smith HE
Vet Microbiol; 2010 Feb; 141(1-2):59-67. PubMed ID: 19709818
[TBL] [Abstract][Full Text] [Related]
28. Heat-killed Streptococcus suis capsular type 2 strains stimulate tumor necrosis factor alpha and interleukin-6 production by murine macrophages.
Segura M; Stankova J; Gottschalk M
Infect Immun; 1999 Sep; 67(9):4646-54. PubMed ID: 10456911
[TBL] [Abstract][Full Text] [Related]
29. Increase of capsular material thickness following in vivo growth of virulent Streptococcus suis serotype 2 strains.
Quessy S; Dubreuil JD; Jacques M; Malouin F; Higgins R
FEMS Microbiol Lett; 1994 Jan; 115(1):19-26. PubMed ID: 8125242
[TBL] [Abstract][Full Text] [Related]
30. Relationship between intracellular survival in macrophages and pathogenicity of Streptococcus suis type 2 isolates.
Williams AE
Microb Pathog; 1990 Mar; 8(3):189-96. PubMed ID: 2199755
[TBL] [Abstract][Full Text] [Related]
31. Intracellular survival and replication of Erysipelothrix rhusiopathiae within murine macrophages: failure of induction of the oxidative burst of macrophages.
Shimoji Y; Yokomizo Y; Mori Y
Infect Immun; 1996 May; 64(5):1789-93. PubMed ID: 8613392
[TBL] [Abstract][Full Text] [Related]
32. The protective protein Sao (surface antigen one) is not a critical virulence factor for Streptococcus suis serotype 2.
Roy D; Fittipaldi N; Dumesnil A; Lacouture S; Gottschalk M
Microb Pathog; 2014; 67-68():31-5. PubMed ID: 24530923
[TBL] [Abstract][Full Text] [Related]
33. Staphylococcus aureus serotype 5 capsular polysaccharide is antiphagocytic and enhances bacterial virulence in a murine bacteremia model.
Thakker M; Park JS; Carey V; Lee JC
Infect Immun; 1998 Nov; 66(11):5183-9. PubMed ID: 9784520
[TBL] [Abstract][Full Text] [Related]
34. The CodY regulator is essential for virulence in Streptococcus suis serotype 2.
Feng L; Zhu J; Chang H; Gao X; Gao C; Wei X; Yuan F; Bei W
Sci Rep; 2016 Feb; 6():21241. PubMed ID: 26883762
[TBL] [Abstract][Full Text] [Related]
35. Characterization and protective activity of a monoclonal antibody against a capsular epitope shared by Streptococcus suis serotypes 1, 2 and 1/2.
Charland N; Jacques M; Lacouture S; Gottschalk M
Microbiology (Reading); 1997 Nov; 143 ( Pt 11)():3607-3614. PubMed ID: 9387239
[TBL] [Abstract][Full Text] [Related]
36. [Anti-phagocytosis mechanism of SalK/SalR, a two-component regulatory system of Streptococcus suis serotype 2].
Fu Z; Pian Y; Li X; Zheng Y; Ma S; Yuan Y; Huo C
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2013 Jun; 29(6):570-3. PubMed ID: 23746237
[TBL] [Abstract][Full Text] [Related]
37. A naturally occurring nucleotide polymorphism in the orf2/folc promoter is associated with Streptococcus suis virulence.
de Greeff A; Buys H; Wells JM; Smith HE
BMC Microbiol; 2014 Nov; 14():264. PubMed ID: 25384512
[TBL] [Abstract][Full Text] [Related]
38. Identification of six novel capsular polysaccharide loci (NCL) from Streptococcus suis multidrug resistant non-typeable strains and the pathogenic characteristic of strains carrying new NCLs.
Huang J; Liu X; Chen H; Chen L; Gao X; Pan Z; Wang J; Lu C; Yao H; Wang L; Wu Z
Transbound Emerg Dis; 2019 Mar; 66(2):995-1003. PubMed ID: 30676694
[TBL] [Abstract][Full Text] [Related]
39. Streptococcus suis capsular polysaccharide inhibits phagocytosis through destabilization of lipid microdomains and prevents lactosylceramide-dependent recognition.
Houde M; Gottschalk M; Gagnon F; Van Calsteren MR; Segura M
Infect Immun; 2012 Feb; 80(2):506-17. PubMed ID: 22124659
[TBL] [Abstract][Full Text] [Related]
40. Phagocytosis and intracellular killing of serum-opsonized Staphylococcus aureus by mouse fibroblasts expressing human Fcgamma receptor type IIa (CD32).
Nibbering PH; Broug-Holub E; Bezemer AC; Jansen R; van de Winkel JG; Geertsma MF
Front Biosci; 1996 Apr; 1():a25-33. PubMed ID: 9159191
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
